Australia is redesigning its vaccination program following concerns about the risk of blood clots from the AstraZeneca Plc vaccine.
Thus, as broadcast by AMPE, doubled Pfizer I vaccine ordersnc against COVID-19, as Prime Minister Scott Morrison stated today.
Until late last night, Thursday night, Australia based most of its vaccination program on one vaccination dose with AstraZeneca vaccine, with an order of 50 million installments. These doses were sufficient for the two vaccine doses of the country’s total population of 25 million, domestically produced by biopharma CSL Ltd.
However, Australia has now followed suit with a number of other countries, limiting the use of the AstraZeneca vaccine due to concerns about thrombosis.
Local health authorities have changed their recommendation, announcing that the estimated 12 million people under the age of 50 should get the Pfizer vaccine.
As a result, Australia doubled its previous order for the Pfizer vaccine, at 40 million doses, enough to cover 4/5 of its population, and those doses may be available by the end of the year, Morrison said.
The policy change for the use of the Pfizer vaccine terminates plans to vaccinate the entire population by the end of October.
“It is not a ban on the AstraZeneca vaccine. “For those over the age of 50, there is strong encouragement to get this AstraZeneca vaccine,” Morrison told reporters after a national government meeting to discuss a plan to tackle it. coronavirus.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
